All Type of News


War of words between prosecution and defendant over former witness’s testimony

The prosecution and the defense counsel had a tense war of nerves over questioning the former Novartis employee, who accepted provision of rebates via specialized magazines and service companies. The Criminal Departm...

What is the main reason for low profitability of multinational pharma?

It was observed the multinational pharmaceutical companies’ sales cost rate reached 70%. The ratio was higher than the one of Korean pharmaceutical companies, 60%. It was criticized, that is, the reason why they have...

MSD Korea’s antibody, Zerbaxa’s approval in Korea

‘Zerbaxa(generic name: ceftolozane+tazobactam),’ a MSD Korea’s(CEO Avi BenShoshan) new antibody, acquired sales approval in Korea. On the 7th, the Ministry of Food and Drug Safe...

MOTIE’s active support on ‘Personalized drug development and promotion on biopharmaceutical startups’

In order to become a pharmaceutical power in the world, the government will be active in promoting startups in the new personalized drug development and biopharmaceutical fields. The Ministry of Trade, Industry and E...

Pharma distributors narrowly increased in operating profit and net profit

Last year, pharmaceutical distribution companies were narrowly increased in operating profit and net profit. According to the analysis result of 146 pharmaceutical distribution companies’ 2016 audit reports turned in...

6 of 10 pharma distribution companies recorded increase of sales costs

It was observed 6 of 10 pharmaceutical distribution companies had difficulties with the enlarged sales costs in the total sales. According to the analysis result of 145 pharmaceutical distribution companies’ 2016 aud...

Multinational pharmas with increased sales, but decreased profitability

Multinational pharmaceutical companies which branched in Korea recorded 7% higher sales, but decreased operating profits and net profits last year. According to the Yakup Shinmoon’s(www.yakup.com) analysis result of ...

BAI, “Hanmi truly delayed the report about ‘Olita,’ but no intention was found”

The Hanmi Pharm’s delayed report on the side effect of ‘Olita Tab’ was officially confirmed. According to audit result on the Hanmi Pharm’s clinical trial for Olita Tab, requested by the National Assembly, the Board ...

Regarding delayed report over Olita side effects, Hanmi will do best not to happen again

Regarding the Board of Audit and Inspection’s audit result that it took 14 months for the SJS(Stevens-Johnson syndrome) occurrence to be reported to the Ministry of Food and Drug Safety(MFDS), Hanmi Pharm explained “T...

Pharma distribution field opposes to EZmedicom’s entry to drug bidding market

The pharmaceutical distribution field has made strong opposition to the EZmedicom’s entry to the drug bidding market. According to the industry concerned on the 18th, Inje Education Foundation, a foundation of Paik H...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.